Aim: The aim of this study was to evaluate the clinical and laboratory features and prognosis of scorpion stings in children.Methods: This was a retrospective study of children with scorpion stings, who were admitted to the pediatric emergency department in Alanya Alaaddin Keykubat University (ALKU) Training and Research Hospital between the 1st of January 2019 and the 31st of December 2020. Demographic data, admission date, time periods from sting to admission to hospital and geographical location in which the sting occurred were recorded. Recordings were also made of the affected body sites, local and systemic signs and symptoms of envenomation, results of hematological and biochemical laboratory tests, management, length of hospital stay and outcome.Results: In total, medical records of 111 children were reviewed. Patients were separated according to the clinical findings into three groups, seventy patients (63.1%) with mild symptoms and thirty-four patients (30.6%) with moderate symptoms, seven patients (6.3%) with severe symptoms. There was one exitus due to scorpion stings in the study period. Forty-one (37%) patients were hospitalised, and seven patients (6.3%) were hospitalised in the pediatric intensive care unit. Five patients (4%) received doxazosin and nineteen (17%) patients had antivenom therapy. Hospitalization in the intensive care unit was necessary for seven cases. No patient exhibited sequelae at the hospital discharge.Conclusions: Scorpion stings in our region mostly result in mild envenomation. Doxazosin, an analog of prazosin more readily available in our country, can be considered as a treatment option in serious scorpion envenomations with significant sympathetic symptoms.
1 February 2025 in Pediatric Academic Case Reports
Costochondral pain can be a diagnostic challenge, especially following an acute disease. We present the case of a 16-year-old female patient who presented with developed severe costochondral pain following influenza A-related pneumonia. Despite initial treatment, her symptoms worsened, leading to significant impairment in her daily activities. Comprehensive investigations, including laboratory tests and imaging studies, were inconclusive. However, treatment with methylprednisolone led to a dramatic improvement in her symptoms. This case highlights the significance of considering inflammatory processes in the differential diagnosis of costochondral pain, especially in adolescents.
Aim: The objective of this study was to systematically evaluate the knowledge levels, clinical practices, and perceive barriers to early childhood neurodevelopmental assessment among family physicians working in primary care settings.Methods: This cross-sectional study included 121 family physicians who had been actively working for at least six months in two districts and volunteered to participate in the research. A 23-item structured questionnaire, developed based on current literature, was utilized as the data collection tool. Data were collected between November 15 and December 31, 2025.Results: The majority of physicians conducting early neurodevelopmental assessments stated that they based their evaluations on clinical observation and physical examination. Only 2 (1.9%) reported using a standard screening tool. Forty participants (33.0%) stated that they had never heard of any developmental screening tests before. The most frequently reported barrier to implementation was insufficient examination time, followed by workload and difficulty accessing appropriate tools. Red flag knowledge levels were scored out of 10, with a median value of 6 (4-7). There was no statistically significant difference between red flag knowledge scores and having previously received training in developmental assessment (p=0.3), professional experience (p=0.87), or level of professional education (p=0.7). Conclusion: The absence of significant differences in neurodevelopmental knowledge scores based on previous training indicates that current training models have limited effectiveness in improving clinical competence. Furthermore, time constraints and insufficient use of standardized screening tools underscore the concrete need for structured support at the primary care level. Training models that strengthen physicians' practical skills and brief screening tools integrated into routine practice will enable more effective monitoring of neurodevelopmental processes at the primary care level.